XML 16 R7.htm IDEA: XBRL DOCUMENT v3.22.1
CONDENSED CONSOLIDATED STATEMENTS OF SHAREHOLDERS' EQUITY - USD ($)
$ in Thousands
Total
Common stock
Additional paid-in capital
Retained earnings
Accumulated other comprehensive income (loss)
Treasury stock
Noncontrolling interest in consolidated subsidiaries
Beginning balance at Dec. 26, 2020 $ 1,207,836 $ 27,900 $ 335 $ 2,245,035 $ (309,786) $ (781,422) $ 25,774
Increase (Decrease) in Shareholders' Equity              
Net earnings 55,001     55,014     (13)
Other comprehensive income (loss) 1,757       2,230   (473)
Cash dividends declared (10,625)     (10,625)      
Purchase of treasury shares, shares acquired (11,131)         (11,131)  
Stock plan exercises, shares acquired (16,725)         (16,725)  
Stock options exercised 19,318   (4,600) (7,069)   30,987  
Stock option expense 648   648        
Stock awards 4,023   3,617     406  
Ending balance at Mar. 27, 2021 1,250,102 27,900 0 2,282,355 (307,556) (777,885) 25,288
Beginning balance at Dec. 25, 2021 1,413,597 27,900 1,479 2,394,307 (263,127) (773,712) 26,750
Increase (Decrease) in Shareholders' Equity              
Net earnings 62,906     62,311     595
Other comprehensive income (loss) 32,060       30,967   1,093
Cash dividends declared (11,721)     (11,721)      
Stock plan exercises, shares acquired (2,527)         (2,527)  
Stock options exercised 713   (536)     1,249  
Stock option expense 716   716        
Stock awards 8,747   3,592     5,155  
Ending balance at Mar. 26, 2022 $ 1,504,491 $ 27,900 $ 5,251 $ 2,444,897 $ (232,160) $ (769,835) $ 28,438